Novel biomarkers for HNSCC that could be used for NB-PDT are emerging, such as CD44, c-Met and PD-L1 [41, 44], but further studies are warranted and their presence in feline OSCC is unknown. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.